These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4632473)

  • 21. Nitroglycerin ointment - a drug with sustained efficacy in angina pectoris.
    Singh S; Agarwal BL; Kumar K; Misra A; Shukla SK; Shukla SR
    J Assoc Physicians India; 1982 Apr; 30(4):219-21. PubMed ID: 6820655
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of buccal nitroglycerin and sublingual nitroglycerin in the prophylaxis and treatment of exertional (situation-provoked) angina pectoris.
    Bray CL; Jain S; Faragher EB; Myers A; Myers P; MacIntyre P; Rae A; Goldman M; Alcorn M
    Eur Heart J; 1991 May; 12 Suppl A():16-20. PubMed ID: 1908385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained action glyceryl trinitrate in the treatment of angina pectoris.
    Evangelista I
    J Lancet; 1968 May; 88(5):111-4. PubMed ID: 4968804
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation].
    Mikunis RI; Monastyrskiĭ IuI; Zhebel' VN; Serkova VK; Bogach NT
    Kardiologiia; 1987 Mar; 27(3):99-101. PubMed ID: 3108565
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of sustained-release buccal nitroglycerin in patients with angina pectoris. New and long-acting therapy demonstrated by exercise.
    Greengart A; Lichstein E; Hollander G; Bolton S; Sanders M
    Chest; 1983 Mar; 83(3):473-9. PubMed ID: 6402342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of the effectiveness of average therapeutic doses of sustac and obzidan in patients with exertional angina pectoris].
    Nazarenko VA; Savvateev KL; Mazur NA
    Kardiologiia; 1982 Sep; 22(9):42-6. PubMed ID: 6815367
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man.
    Hirshleifer I
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
    Roy P; Day L; Sowton E
    Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duration of the hemodynamic effect of various doses of delayed-action nitroglycerin preparations].
    Savvateev KL; Metelitsa VI; Vygodin VA
    Kardiologiia; 1983 Feb; 23(2):55-61. PubMed ID: 6405071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excessive reduction in peripheral resistance during exercise and risk of orthostatic symptoms with sustained-release nitroglycerin and diltiazem treatment of angina.
    Bruce RA; Hossack KF; Kusumi F; Day B; Kannagi T
    Am Heart J; 1985 May; 109(5 Pt 1):1020-6. PubMed ID: 3922207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glyceryl trinitrate ointment in angina pectoris.
    Salem HH; Singh SP
    Postgrad Med J; 1979 Dec; 55(654):874-6. PubMed ID: 121456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
    Prichard BN; Gillam PM
    Br Heart J; 1971 Jul; 33(4):473-80. PubMed ID: 4997528
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nitrite therapy of stenocardia].
    Meesmann W; Amann L
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
    [No Abstract]   [Full Text] [Related]  

  • 37. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind crossover study of diphenylhydantoin in angina pectoris.
    Taylor CR
    Chest; 1974 Oct; 66(4):422-7. PubMed ID: 4213041
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
    Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A
    Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.
    Goldstein RE; Rosing DR; Redwood DR; Beiser GD; Epstein SE
    Circulation; 1971 May; 43(5):629-40. PubMed ID: 4996159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.